A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas

NCT01163071 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ABI-011

Sponsor

Celgene

Collaborators

[object Object]